Our results suggest that there is a good overlap between CR-1high ECSLCs and ALDH1A1high ECSLCs, therefore CR-1 together with ALDH1A1 can be applied as useful biomarkers to predict the outcome of ESCC patients. Here, ALDH1A1 is linked to esophageal squamous cell carcinoma.